Sites Articles

Quintiles' Phase I Unit Tackles Trial 'Shopping'

Aug 14, 2015

By Moe Alsumidaie

Clinical trial recruitment and enrollment has presented its challenges in many ways.

Improving Minority Recruitment in Clinical Trials

Aug 11, 2015

By Bernadette Tosti

Promising new approaches to optimize data and outcomes.

Five Steps to Increase Site Satisfaction and Study Success

Jul 31, 2015

By Elizabeth Dalton

Over the past three decades, clinical imaging has become an integral part of the drug development process for biopharmaceutical companies.

TransCelerate’s eLabeling Initiative

Apr 22, 2015

By Moe Alsumidaie

TransCelerate recently announced a new initiative focused on eLabeling in clinical trials. The eLabels Initiative is expected to improve label usage for patients, streamline labeling approaches at sites and create opportunities to decrease timelines in the investigational supply chain resulting in cost efficiencies for sponsors.

Examining the Stats: The “One Time” Investigator

Apr 22, 2015

By Harold E. Glass, PhD

Do 50% of US investigators only conduct one clinical trial? Much of the misunderstanding behind this “one time” claim, which first surfaced in the 1990s, rests on a misunderstanding of the BMIS.

Sites News

Kayentis Chooses SFR M2M for Roaming

Kayentis, a French software provider specialized in solutions for clinical trials, has chosen SFR Business Team for its M2M roaming in close to 250 countries.

goBalto Joins as SCRS Partner

goBalto represents a handful of technology solution companies that have openly endorsed their commitment to clinical research sites.

Duke Chooses Greenphire’s Automated Payment System

Duke University has selected Greenphire's ClinCard system to support financial data management and tracking of payments to research participants.

Protocol Builder Available to Individual Researchers

Cloud-based solution allows investigators to simplify the development of clinical research protocols.

Isis Pharma Utilizes Site Specific CRO for Study

The New England Journal of Medicine recently published results of a multi-center Phase II clinical trial, managed by CTMG.